GAD2 and type 1 diabetes mellitus: In this study, our findings demonstrate that oral administration of the GAD65-L. lactis vaccine effectively induces antigen-specific regulatory T cells and tolerance, enhances TGF-β secretion, and mitigates T1D development in NOD mice.